← All stocks

Neumora Therapeutics, Inc.

NMRA Net buying

CIK 0001885522 #3643 in the set updated 18 Sep 2026

Bought (12 mo)

$15.00M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$1.09M

$312.14K on a plan · $701.64K straight out of an exercise

Sold at will

$77.47K

3 of 16 sales

Net

+$13.91M

+$14.92M against sales at will

By person

9 insiders · 19 transactions

16.8×

Paul L. Berns holds 16.8 times base salary in stock. $11.80M of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Paul L. Berns last reported holding, valued at $1.60, the price Common Stock was last bought or sold at on the open market here, on 21 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

ARCH Venture Partners X, LLC entity

10% owner

$5.00M (1)

—

+$5.00M

6,046,907

3.22%

$9.65M

+46.4%

ARCH Venture Partners XII, LLC entity

10% owner

$5.00M (1)

—

+$5.00M

6,046,907

3.22%

$9.65M

+46.4%

Burow Kristina

Director

$5.00M (1)

—

+$5.00M

6,046,907

3.22%

$9.65M

+46.4%

Aurora Daljit Singh

See Remarks

—

$1.03M (13) scheduled

−$1.03M

48,750

0.0259%

$77.80K

−77.0%

BERNS PAUL L

See Remarks

—

$34.46K (1)

−$34.46K

7,395,185

3.94%

$11.80M

−5.4%

Pinto Joshua

President & CEO

—

$21.09K (1)

−$21.09K

209,950

0.1117%

$335.04K

−6.3%

Milligan Michael Lee

See Remarks

—

$5.12K (1) scheduled

−$5.12K

21,034

0.0112%

$33.57K

−14.0%

Lenz Robert A.

Head of R&D

—

309,092

0.1645%

$493.25K

−8.9%

Fust Matthew K

Director

—

20,100

0.0107%

$32.08K

0.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

ARCH Venture Partners X, LLC

27 Oct 2025

10% owner

Buy indirect

1,915,700

$2.61

$5.00M

ARCH Venture Partners XII, LLC

27 Oct 2025

10% owner

Buy indirect

1,915,700

$2.61

$5.00M

Burow Kristina

27 Oct 2025

Director

Buy indirect

1,915,700

$2.61

$5.00M

Show all 19 transactions →

What was left out

Form 4 filings counted 24

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 2

Sales on a Rule 10b5-1 plan 2

Sales straight out of an exercise 11

Sales at will 3

Transactions with no price 0

Shares from compensation/vesting 419,813

History held since 18 Sep 2023